Enhanced tissue expression and elevated circulating level of phospholipaseA(2) receptor during murine endotoxic shock

Citation
Y. Yokota et al., Enhanced tissue expression and elevated circulating level of phospholipaseA(2) receptor during murine endotoxic shock, ARCH BIOCH, 379(1), 2000, pp. 7-17
Citations number
46
Categorie Soggetti
Biochemistry & Biophysics
Journal title
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
ISSN journal
00039861 → ACNP
Volume
379
Issue
1
Year of publication
2000
Pages
7 - 17
Database
ISI
SICI code
0003-9861(20000701)379:1<7:ETEAEC>2.0.ZU;2-V
Abstract
Phospholipase A(2) receptor (PLA(2)R) mediates a variety of biological resp onses elicited by mammalian secretory phospholipase A(2) (sPLA(2)). In mice , group IB sPLA(2) (sPLA(2)-IB) acts as an endogenous ligand of PLA(2)R, an d analysis of PLA(2)R-deficient mice has demonstrated a critical role of th e sPLA(2)-IB/PLA(2)R system in the production of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) in the development of endot oxic shock. Here, we generated specific antibodies against a recombinant so luble form of PLA(2)R and examined its expression in the lung and spleen wh ere a remarkable elevation of TNF-alpha expression has been observed during endotoxemia. Immunohistochemical analysis revealed the expression of PLA(2 )R in type II alveolar epithelial cells and a subset of splenic lymphocytes , and its expression levels were markedly enhanced at 1 h after endotoxin c hallenge. Analysis with a newly developed sandwich enzyme-linked immunosorb ent assay system revealed the presence of a soluble form of PLA(2)R in plas ma of wild-type mice compared with its absence in plasma of PLA(2)R-deficie nt mice. After exposure to endotoxin, its circulating level was significant ly elevated to the maximum level at 2-3 h after the treatment. These result s suggest that tissue expression and the circulating level of PLA(2)R are e levated during murine endotoxemia, which might be relevant to its potential roles in the production of proinflammatory mediators during the developmen t of inflammatory conditions. (C) 2000 Academic Press.